Increase of Survival Benefit in Advanced Resectable Colon Cancer by Extent of Adjuvant Treatment: Results of a Randomized Trial Comparing Modulation of 5-FU + Levamisole With Folinic Acid or With Interferon-α : Annals of Surgery

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Randomized, Controlled Trials

Increase of Survival Benefit in Advanced Resectable Colon Cancer by Extent of Adjuvant Treatment

Results of a Randomized Trial Comparing Modulation of 5-FU + Levamisole With Folinic Acid or With Interferon-α

Link, Karl-Heinz MD*; Kornmann, Marko MD*; Staib, Ludger MD*; Redenbacher, Martin MD; Kron, Martina PhD; Beger, Hans Günter MD*

Author Information
doi: 10.1097/01.sla.0000171033.65639.a9
  • Buy

© 2005 Lippincott Williams & Wilkins, Inc.